Sustainability | July 10, 2024
Synexa Life Sciences enrolls in My Green Lab Certification Program
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
AIIMS Jammu is a beacon of hope not only for the people of J&K, but also for that of Leh, and other neighboring states
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Subscribe To Our Newsletter & Stay Updated
